Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
HSBC Continental Europe: Pre Stabilisation Notice
-
NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Outstanding Drill Results at the Cowboy State Mine area for Wyoming Rare (USA) Inc.
-
Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board
-
Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
-
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs
-
Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)
-
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional “Decision to Grant” Communications
-
United Community Banks, Inc. and 21st Mortgage Corporation Close Sale of Manufactured Housing Loan Portfolio
-
Humacyte to Participate at Upcoming Investor Conferences in September
-
Conifer Holdings Sells Insurance Agency Operations, Promotes Brian Roney to Chief Executive Officer
-
Uniti Announces New Contract Award with Large Hyperscaler
-
New Secondary Analysis of Phase 3 Data Demonstrates that INPEFA® (Sotagliflozin) Benefited Heart Failure Patients Regardless of Diabetes Duration
-
Avalyn Announces Initiation of its Global Phase 2b MIST Study of AP01 Inhaled Pirfenidone for Progressive Pulmonary Fibrosis
-
VYNE Therapeutics to Participate in September Investor Conferences
-
Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial
-
Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML
-
RedDress Announces Randomized Controlled Trial Results Showing Significant Benefits of ActiGraft Pro for Diabetic Foot Ulcers
-
Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extend
-
Rectify Pharmaceuticals Appoints Pol Boudes as Chief Medical Officer
-
Enviri Corporation to participate in upcoming investor conferences
-
The Chefs’ Warehouse, Inc. to Participate in CL King’s 22nd Best Ideas Conference
-
University of Mississippi Medical Center Launches Student Loan Benefit with Fiducius to Support Employee Recruiting and Retentions Efforts
-
LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
-
First Federal Savings Bank and ICBA: Take Steps to Safeguard Your Finances During National Preparedness Month
-
IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
-
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
-
Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Golden State Wealth Management Welcomes New Advisor, Valerie Krebs
-
Cogent Biosciences Announces Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST) Has Completed Enrollment and Advanced Past Interim Futility Analysis
-
RTI to Exhibit at AFA’s Air, Space and Cyber Conference 2024
-
Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Compass Therapeutics to Participate in Upcoming Investor Events
-
New HealthEquity Partnership Enhances Employee Access to Healthcare
-
Orbital Materials Launches “Orb”, the World’s Leading AI Model for Advanced Materials
-
Worksport’s New Sales Initiative Surges with Strong Early Momentum
-
Freshpet Appoints Nicki Baty as Chief Operating Officer
-
Belite Bio to Participate in Three Upcoming Investor Conferences
-
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
-
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Indonesia Energy to Present at H.C. Wainwright 26th Annual Global Investment Conference
-
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
-
Kartoon Studios and LiveOne to Collaborate on Custom Audio and Video Channels
-
Ocean Power Technologies Receives Further Contract for PowerBuoy® Deployment with Naval Postgraduate School
-
Phunware to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Full House Resorts Announces Sale of Stockman’s Casino for $9.2 Million
-
American Hotel Income Properties REIT LP Announces Strategic Dispositions
-
BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024
-
Skyline Bankshares, Inc. and Skyline National Bank Complete Merger with Johnson County Bank

